HETEROAROMATIC COMPOUNDS AS BTK INHIBITORS

wherein the groups R1, Cy and Y are defined herein, which are suitable for the treatment of diseases related to BTK, and processes for making these compounds, pharmaceutical preparations containing these compounds, and their methods of use.

Saved in:
Bibliographic Details
Main Authors TSCHANTZ, Matt Aaron, BOSANAC, Todd, SHEN, Yue, BURKE, Michael Jason, SOLEYMANZADEH, Fariba, BENTZIEN, Joerg, MAO, Wang, FRYER, Ryan Michael, MCKIBBEN, Bryan Patrick, LARSON, Eric Thomas
Format Patent
LanguageEnglish
Published 09.08.2018
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:wherein the groups R1, Cy and Y are defined herein, which are suitable for the treatment of diseases related to BTK, and processes for making these compounds, pharmaceutical preparations containing these compounds, and their methods of use.
Bibliography:Application Number: US201815947978